159 related articles for article (PubMed ID: 38683453)
1. Oxidative Stress-Mediated RUNX3 Mislocalization Occurs Via Jun Activation Domain-Binding Protein 1 and Histone Modification.
Kang KA; Piao MJ; Fernando PDSM; Herath HMUL; Boo HJ; Yoon SP; Hyun JW
Appl Biochem Biotechnol; 2024 Apr; ():. PubMed ID: 38683453
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic Localization of RUNX3 via Histone Deacetylase-Mediated SRC Expression in Oxidative-Stressed Colon Cancer Cells.
Kang KA; Piao MJ; Ryu YS; Maeng YH; Hyun JW
J Cell Physiol; 2017 Jul; 232(7):1914-1921. PubMed ID: 27990641
[TBL] [Abstract][Full Text] [Related]
3. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
Lee SH; Kim J; Kim WH; Lee YM
Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic changes induced by oxidative stress in colorectal cancer cells: methylation of tumor suppressor RUNX3.
Kang KA; Zhang R; Kim GY; Bae SC; Hyun JW
Tumour Biol; 2012 Apr; 33(2):403-12. PubMed ID: 22274925
[TBL] [Abstract][Full Text] [Related]
5. Jab1/CSN5 induces the cytoplasmic localization and degradation of RUNX3.
Kim JH; Choi JK; Cinghu S; Jang JW; Lee YS; Li YH; Goh YM; Chi XZ; Lee KS; Wee H; Bae SC
J Cell Biochem; 2009 Jun; 107(3):557-65. PubMed ID: 19350572
[TBL] [Abstract][Full Text] [Related]
6. Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasm.
Goh YM; Cinghu S; Hong ETH; Lee YS; Kim JH; Jang JW; Li YH; Chi XZ; Lee KS; Wee H; Ito Y; Oh BC; Bae SC
J Biol Chem; 2010 Mar; 285(13):10122-10129. PubMed ID: 20100835
[TBL] [Abstract][Full Text] [Related]
7. RUNX3 methylation drives hypoxia-induced cell proliferation and antiapoptosis in early tumorigenesis.
Lee SH; Hyeon DY; Yoon SH; Jeong JH; Han SM; Jang JW; Nguyen MP; Chi XZ; An S; Hyun KG; Jung HJ; Song JJ; Bae SC; Kim WH; Hwang D; Lee YM
Cell Death Differ; 2021 Apr; 28(4):1251-1269. PubMed ID: 33116296
[TBL] [Abstract][Full Text] [Related]
8. Control of RUNX3 by histone methyltransferases.
Lee YM
J Cell Biochem; 2011 Feb; 112(2):394-400. PubMed ID: 21268059
[TBL] [Abstract][Full Text] [Related]
9. Lactam-based HDAC inhibitors for anticancer chemotherapy: restoration of RUNX3 by posttranslational modification and epigenetic control.
Cho M; Choi E; Kim JH; Kim H; Kim HM; Lee JI; Hwang KC; Kim HJ; Han G
ChemMedChem; 2014 Mar; 9(3):649-56. PubMed ID: 24376239
[TBL] [Abstract][Full Text] [Related]
10. Interaction of DNA demethylase and histone methyltransferase upregulates Nrf2 in 5-fluorouracil-resistant colon cancer cells.
Kang KA; Piao MJ; Ryu YS; Kang HK; Chang WY; Keum YS; Hyun JW
Oncotarget; 2016 Jun; 7(26):40594-40620. PubMed ID: 27259240
[TBL] [Abstract][Full Text] [Related]
11. Loss of expression rather than cytoplasmic mislocalization of RUNX3 predicts worse outcome in non-small cell lung cancer.
Chen X; Deng Y; Shi Y; Zhu W; Cai Y; Xu C; Zhu K; Zheng X; Chen G; Xie Q; Weng G
Oncol Lett; 2018 Apr; 15(4):5043-5055. PubMed ID: 29545901
[TBL] [Abstract][Full Text] [Related]
12. PDT-induced epigenetic changes in the mouse cerebral cortex: a protein microarray study.
Demyanenko SV; Uzdensky AB; Sharifulina SA; Lapteva TO; Polyakova LP
Biochim Biophys Acta; 2014 Jan; 1840(1):262-70. PubMed ID: 24055374
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Orally Available Runt-Related Transcription Factor 3 (RUNX3) Modulators for Anticancer Chemotherapy by Epigenetic Activation and Protein Stabilization.
Yang JS; Lee C; Cho M; Kim H; Kim JH; Choi S; Oh SJ; Kang JS; Jeong JH; Kim HJ; Han G
J Med Chem; 2015 Apr; 58(8):3512-21. PubMed ID: 25811792
[TBL] [Abstract][Full Text] [Related]
14. Coordinated recruitment of histone methyltransferase G9a and other chromatin-modifying enzymes in SHP-mediated regulation of hepatic bile acid metabolism.
Fang S; Miao J; Xiang L; Ponugoti B; Treuter E; Kemper JK
Mol Cell Biol; 2007 Feb; 27(4):1407-24. PubMed ID: 17145766
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of RUNX3 protein expression in tongue squamous cell carcinoma and its association with clinicopathological characteristics.
Zhou WN; Du YF; Zheng Y; Zhang W; Wu YN; Song XM; Bai J
Mol Med Rep; 2019 Feb; 19(2):885-894. PubMed ID: 30535462
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction.
Mabuchi M; Kataoka H; Miura Y; Kim TS; Kawaguchi M; Ebi M; Tanaka M; Mori Y; Kubota E; Mizushima T; Shimura T; Mizoshita T; Tanida S; Kamiya T; Asai K; Joh T
Biochem Biophys Res Commun; 2010 Jul; 398(2):321-5. PubMed ID: 20599712
[TBL] [Abstract][Full Text] [Related]
17. Improving potency and metabolic stability by introducing an alkenyl linker to pyridine-based histone deacetylase inhibitors for orally available RUNX3 modulators.
Song D; Lee C; Kook YJ; Oh SJ; Kang JS; Kim HJ; Han G
Eur J Med Chem; 2017 Jan; 126():997-1010. PubMed ID: 28011426
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of TrkB Expression and Signaling by Valproic Acid and Other Histone Deacetylase Inhibitors.
Dedoni S; Marras L; Olianas MC; Ingianni A; Onali P
J Pharmacol Exp Ther; 2019 Sep; 370(3):490-503. PubMed ID: 31308194
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress induces proliferation of colorectal cancer cells by inhibiting RUNX3 and activating the Akt signaling pathway.
Kang KA; Kim KC; Bae SC; Hyun JW
Int J Oncol; 2013 Nov; 43(5):1511-6. PubMed ID: 24042352
[TBL] [Abstract][Full Text] [Related]
20. Histone demethylase Jumonji domain-containing 1A inhibits proliferation and progression of gastric cancer by upregulating runt-related transcription factor 3.
Ning K; Shao Y; He Y; Wang F; Cui X; Liu F; Li D; Li F
Cancer Sci; 2020 Oct; 111(10):3679-3692. PubMed ID: 32762126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
